Editorial
doi: 10.1001/jamaneurol.2018.1010.
Improving Evaluation of Patients With Cognitive Impairment With Amyloid Positron Emission Tomography
Affiliations
- PMID: 29889928
- DOI: 10.1001/jamaneurol.2018.1010
Item in Clipboard
Editorial
Improving Evaluation of Patients With Cognitive Impairment With Amyloid Positron Emission Tomography
JAMA Neurol.
.
No abstract available
Comment on
-
Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.JAMA Neurol. 2018 Sep 1;75(9):1062-1070. doi: 10.1001/jamaneurol.2018.1346. JAMA Neurol. 2018. PMID: 29889941 Free PMC article.
Similar articles
-
Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment.Stroke. 2016 Oct;47(10):2645-8. doi: 10.1161/STROKEAHA.116.013778. Epub 2016 Aug 18. Stroke. 2016. PMID: 27539301
-
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.Brain. 2014 Jan;137(Pt 1):221-31. doi: 10.1093/brain/awt286. Epub 2013 Oct 30. Brain. 2014. PMID: 24176981
-
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334. Brain. 2017. PMID: 28077397 Free PMC article.
-
Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.Brain. 2016 Sep;139(Pt 9):2516-27. doi: 10.1093/brain/aww148. Epub 2016 Jun 21. Brain. 2016. PMID: 27329772
-
Amyloid and Tau Biomarkers in Subjective Cognitive Impairment.J Alzheimers Dis. 2015;47(1):1-8. doi: 10.3233/JAD-150180. J Alzheimers Dis. 2015. PMID: 26402749 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
